$LIFE aTYR PHARMA INC Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in aTYR PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in aTYR PHARMA INC. Find out how many shares they currently own, their value and whether they buy or sell their shares.
aTYR PHARMA INC Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| AKKARAJU SRINIVAS | Director | 1,866,126 | 6,344,828 | May 11 2017 | |||
| Alta Partners VIII, L.P. | 10% Owner | 1,778,064 | 6,045,418 | May 14 2015 | |||
| Amanullah Ashraf | See Remarks | 26,264 | 89,298 | Jun 07 2018 | |||
| Ashlock Melissa A. | See Remarks | 0 | 0 | Jan 29 2016 | |||
| Blackburn Kelly | VP, Clinical Affairs | 0 | 0 | Mar 30 2016 | |||
| Blackburn Stan | Acting Chief Financial Officer | 0 | 0 | Jan 29 2016 | |||
| BLAIR JAMES C | Director | 0 | 0 | May 10 2019 | |||
| Blake John T | Senior Vice President, Finance | 3,334 | 11,336 | Feb 08 2018 | |||
| Chereau Frederic | President & COO | 0 | 0 | May 08 2015 | |||
| CHP II LP | 10% Owner | 1,758,158 | 5,977,737 | May 14 2015 | |||
| Chrzanowski Holly D. | See Remarks | 0 | 0 | Jan 29 2016 | |||
| Church Jill Marie | Chief Financial Officer | 10,223 | 34,758 | Feb 09 2021 | |||
| CLARKE JOHN K | Director | 117,843 | 400,666 | Apr 29 2021 | |||
| Coughlin Timothy P | Director | 0 | 0 | Apr 29 2021 | |||
| Cubitt Andrew | VP, Product Protection | 0 | 0 | Sep 15 2016 | |||
| Domain Partners VIII, L.P. | 10% Owner | 1,807,820 | 6,146,588 | May 12 2015 | |||
| DP VIII Associates, L.P. | 10% Owner | 13,414 | 45,608 | May 12 2015 | |||
| EcoR1 Capital Fund Qualified, L.P. | 10% Owner | 2,854,525 | 9,705,385 | May 16 2018 | |||
| FALBERG KATHRYN E | Director | 0 | 0 | May 26 2016 | |||
| Flynn James E | 10% Owner | 255,764 | 869,598 | May 13 2015 | |||
| Goldberg Mark Alan | Director | 0 | 0 | May 11 2017 | |||
| Graham Marcy | See Remarks | 0 | 0 | Jan 06 2016 | |||
| Gross Jane A | Director | 0 | 0 | Apr 29 2021 | |||
| Hatfield Jeffrey S. | Director | 0 | 0 | May 08 2020 | |||
| King David John | Chief Scientific Officer | 0 | 0 | Feb 08 2018 | |||
| Krueger Nancy | General Counsel | 3,057 | 10,394 | Feb 08 2021 | |||
| Lucas Svetlana | Director | 0 | 0 | Apr 29 2021 | |||
| Matsuoka Grove | See Remarks | 12,412 | 42,201 | Feb 09 2017 | |||
| McKew John C. | VP, Research | 0 | 0 | Jan 29 2016 | |||
| MENDLEIN JOHN | Director | 420,382 | 1,429,299 | May 10 2019 | |||
| Nashat Amir | Director | 17,638 | 59,969 | May 17 2018 | |||
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | 17,638 | 59,969 | May 14 2015 | |||
| Ramsdell Fred | VP, Immunology | 0 | 0 | Oct 05 2015 | |||
| Ravindran Sanuj K. | Chief Business Officer | 0 | 0 | Feb 09 2017 | |||
| SCHIMMEL PAUL | Director | 429,143 | 1,459,086 | Apr 29 2021 | |||
| Shukla Sanjay | President and CEO | 9,076 | 30,858 | Feb 09 2021 | |||
| Sofinnova Venture Partners IX, L.P. | 10% Owner | 1,866,126 | 6,344,828 | May 14 2015 | |||
| Weiner David M. | Chief Medical Officer | 0 | 0 | May 08 2015 | |||
| Zaknoen Sara | Director | 0 | 0 | May 25 2021 |